Harvard Business Review

CEO Series: 23andMe’s Anne Wojcicki on Scientific Breakthroughs and Public Trust

CEO Series: 23andMe’s Anne Wojcicki on Scientific Breakthroughs and Public Trust

Anne Wojcicki, CEO of 23andMe, spent a decade in healthcare and biotechnology before launching the DNA testing and analysis company in 2006. Her goal was twofold: to help individuals learn more about their own genetics, enabling them to pursue more personalized medical care, and to create a database of genetic information for commercial and academic researchers to promote broader improvements to the healthcare system. She speaks with HBR's Editor-in-Chief Adi Ignatius about tackling challenges in an emerging industry.

Duration: 24 min

Release Date:

Share part or all of the audio of this episode